DexCom (NASDAQ: DXCM) reported Q3 EPS of ($0.22), $0.09 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $148.6 million versus the consensus estimate of $146.26 million.

For earnings history and earnings-related data on DexCom (DXCM) click here.